2003
DOI: 10.1007/s00415-003-0260-8
|View full text |Cite
|
Sign up to set email alerts
|

Persistent organic personality change as rare psychiatric manifestation of MELAS syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2005
2005
2011
2011

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 9 publications
0
9
0
Order By: Relevance
“…Signs indicating ADHD in childhood have been reported in a middle-aged female patient with a mtDNA rearrangement [68]. Personality alterations, in some cases followed by cognitive decline, have been described in patients with mitochondrial disease with confirmed mtDNA mutations [34,76].…”
Section: Neuropsychiatric Symptoms Of Childhood and Personality Altermentioning
confidence: 96%
“…Signs indicating ADHD in childhood have been reported in a middle-aged female patient with a mtDNA rearrangement [68]. Personality alterations, in some cases followed by cognitive decline, have been described in patients with mitochondrial disease with confirmed mtDNA mutations [34,76].…”
Section: Neuropsychiatric Symptoms Of Childhood and Personality Altermentioning
confidence: 96%
“…2) [2]. Psychiatric abnormalities in MIDs include impaired consciousness [12], impaired alertness, concentration, orientation, reasoning [13,14], acute or chronic confusional state, hallucinations [13], personality change [14][15][16], or unsteadiness [2,17].…”
Section: Clinical Abnormalitiesmentioning
confidence: 99%
“…Psychiatric abnormalities are a frequent finding in RCDs and include impaired consciousness [27], impairment of alertness, concentration, orientation, reasoning, mood (depression) [28,29], acute or chronic confusional state [30,31], hallucinations [28], or personality change [32][33][34][35][36][37]. Encephalopathic psychosis has been particularly described in patients with mitochondrial encephalomyopathy, lactacidosis, and stroke-like episodes (MELAS) syndrome [38][39][40][41][42].…”
Section: Clinical Presentationmentioning
confidence: 99%